It has been an unusually busy month in lipedema research. Since September 2, a major trial has reported on liposuction and pain, while new studies have explored diet, tirzepatide, gestrinone, shock-wave therapy and the way lipedema pain is measured. There has even been a proposal to change the name of the condition.
If you have seen the headlines, you may be wondering which findings could change care and which are still early clues. That is the question I want to answer in this September 2026 research roundup. I have brought the developments together in one place, explained what each study actually found, and looked at what remains uncertain. Some results are genuinely encouraging. Others are reminders that an interesting observation is the beginning of a research question, not its answer.
